about
New insights into urea and glucose handling by the kidney, and the urine concentrating mechanismProtein- and diabetes-induced glomerular hyperfiltration: role of glucagon, vasopressin, and ureaUrea and urine concentrating ability in mice lacking AQP1 and AQP3Long-term effects of vasopressin on the subcellular localization of ENaC in the renal collecting systemRenal urea transporters. Direct and indirect regulation by vasopressin.Race, sex, and the regulation of urine osmolality: observations made during water deprivationArginine vasopressin gene regulation in the homozygous Brattleboro rat.Extracellular cAMP inhibits proximal reabsorption: are plasma membrane cAMP receptors involved?Antinatriuretic effect of vasopressin in humans is amiloride sensitive, thus ENaC dependent.Metabolic changes in summer active and anuric hibernating free-ranging brown bears (Ursus arctos).Urea transporter UT-B deletion induces DNA damage and apoptosis in mouse bladder urotheliumUrine osmolarity and risk of dialysis initiation in a chronic kidney disease cohort--a possible titration target?Low water intake and risk for new-onset hyperglycemia.Metabolic and Kidney Diseases in the Setting of Climate Change, Water Shortage, and Survival FactorsSex difference in urine concentration across differing ages, sodium intake, and level of kidney disease.Plasma Copeptin, AVP Gene Variants, and Incidence of Type 2 Diabetes in a Cohort From the Community.Impacts of Active Urea Secretion into Pars Recta on Urine Concentration and Urea Excretion Rate.Plasma copeptin and renal outcomes in patients with type 2 diabetes and albuminuria.A case for water in the treatment of polycystic kidney disease.Urinary Sodium Concentration Is an Independent Predictor of All-Cause and Cardiovascular Mortality in a Type 2 Diabetes Cohort Population.Vasopressin V2 receptors, ENaC, and sodium reabsorption: a risk factor for hypertension?Vasopressin: a novel target for the prevention and retardation of kidney disease?Active urea transport in lower vertebrates and mammals.Possible involvement of vasopressin and urine concentrating process in the progression of chronic renal failure.Hydration and Chronic Kidney Disease Progression: A Critical Review of the Evidence.Glucagon actions on the kidney revisited: possible role in potassium homeostasis.Vasopressin and diabetic nephropathy.Renal function and concentrating ability in a desert rodent: the gundi (Ctenodactylus vali).Rehydration with soft drink-like beverages exacerbates dehydration and worsens dehydration-associated renal injury.Plasma Copeptin, Kidney Outcomes, Ischemic Heart Disease, and All-Cause Mortality in People With Long-standing Type 1 Diabetes.Relationship between Sodium Intake and Water Intake: The False and the True.Methods for measurement of renal blood flow in man.Urine Osmolarity and Risk of Dialysis Initiation in a CKD Cohort.Direct and indirect cost of urea excretion.Vasopressin-dependent kidney hypertrophy: role of urinary concentration in protein-induced hypertrophy and in the progression of chronic renal failure.Plasma Copeptin and Decline in Renal Function in a Cohort from the Community: The Prospective D.E.S.I.R. Study.Mutation of the Na(+)-K(+)-2Cl(-) cotransporter NKCC2 in mice is associated with severe polyuria and a urea-selective concentrating defect without hyperreninemia.Aquaporin-2 and urea transporter-A1 are up-regulated in rats with type I diabetes mellitus.Vasopressin increases urinary albumin excretion in rats and humans: involvement of V2 receptors and the renin-angiotensin system.Lack of UT-B in vasa recta and red blood cells prevents urea-induced improvement of urinary concentrating ability.
P50
Q27008402-BF6FD38F-1684-4380-A1DE-81E75A19FBCAQ28085593-DA243D43-D8CC-4E6A-B5D3-2DC74EEFDB25Q28510068-FF7AED90-CEFB-4DF4-B3A6-A1B7B903108BQ28571469-4DA69473-1478-475E-9EB0-D02D2B63E54DQ33906410-A95FF36C-3633-48BD-84D1-AF88B4C609A0Q34150253-2139692D-A1F1-4D5B-94B5-5AFFE4F06976Q34254682-B1FF808E-7466-4536-8218-8F65C028500BQ34520624-130B90B3-092B-4941-8CE2-ADF1F55980F1Q34751826-196005AC-66EB-45D8-A9B8-9018F6BD7519Q34988670-D422FC60-6595-42D1-BA1E-814A950BAB52Q35034911-51FF3C0A-3EEB-4645-BA67-9661C91B450CQ35133545-4635C3F6-C7DD-453F-AC77-2157884F0630Q35563596-A7CC73F7-CDF5-4278-9713-3D5E2713A383Q36047669-DB75FFAF-ADEA-4387-B810-A3EC5E2F1E58Q36600774-B793CCA8-D359-43E0-BFD3-2381CEF0F6C4Q36965316-82B172C7-029E-440F-87D7-B2D188D21D86Q37184327-9EB924AA-25DE-4303-9ECB-1144348E73A1Q37278044-C1FA9EB2-FB77-4A75-9979-F45FD85738B0Q37483113-E8BDD19D-A2EF-433C-9605-3D3EA0A3745EQ37642298-F3808AFC-CEF1-4DF8-A053-D8E6FE51414DQ37786447-CE99AB25-6A4B-4233-BC87-B459A909A787Q38084471-3A76D8D2-7601-49BB-BEDE-3E3468A770F8Q38258319-5CA15F2B-FCAD-4F31-A5C3-AE07A9A60E13Q38783482-1E97D418-6192-4017-9171-A4017A3B2EF8Q38830453-3A88F4EC-7D33-4B7B-965F-274BE73C0DD4Q38838119-A6DEFD8B-8A71-411B-8665-A4444052757FQ38840338-F3EFA5C4-CA00-4950-AFB0-219EB7E629A3Q38966892-E7C94851-3A26-49F8-89B8-7A68E11A3449Q39017490-CA08CAF1-6124-4E5F-8AEB-E885CFE6E6BDQ39301615-0FB24E0A-35F1-4DCB-9148-C4C9E1DD45A2Q39373764-E2DE0049-1170-4285-9EBE-7AC56A12C3F3Q39944821-12E07756-CAB8-4B52-8C92-671CA986D84EQ40822671-AE56FE63-E09D-4E30-8300-7BA695ECC43EQ41066590-D99E8FEE-BE08-47C2-9E03-E967F15450DAQ41186759-1D44F9F9-7A1C-451F-90D7-6426A2A4C274Q41394637-7B080973-28C3-442C-9A4D-4907D6EC5353Q43134831-821ED257-DF9D-429D-BA32-4B21A925F582Q43622540-67FEF21B-2BB7-4AF4-BA3D-85D480C83BB1Q44313384-E5FDE4B6-7034-422D-826A-239F19903CD8Q44579264-F03680B8-4861-42B3-A830-6CD0906E5A2A
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Lise Bankir
@ast
Lise Bankir
@en
Lise Bankir
@es
Lise Bankir
@nl
type
label
Lise Bankir
@ast
Lise Bankir
@en
Lise Bankir
@es
Lise Bankir
@nl
prefLabel
Lise Bankir
@ast
Lise Bankir
@en
Lise Bankir
@es
Lise Bankir
@nl
P214
P106
P214
P31
P496
0000-0002-3321-0819
P735
P7859
viaf-204987013